All Stories

  1. Pseudotyped virus-based platform and structural analysis reveal potential cross-reactivity sites between influenza C and D viruses
  2. Direct Virus-Bacteria Binding Enhances Streptococcus equi subsp. zooepidemicus Colonisation and Bacterial-Driven Immune Activation During H3N8 Equine Influenza A Viru...
  3. A Safer and Better Test for Detecting Influenza D in Cattle
  4. Isothermal Detection of Influenza D using RT-LAMP
  5. Report from the 2025 research showcase and open discussion on equine vector‐borne diseases in the UK
  6. Mitochondrial DNA sequencing of horse breeds found in north-west Nigeria
  7. Effectiveness of a screening protocol employed at a UK rescue centre to prevent introduction of strangles
  8. Report from the 2025 research showcase & open discussion on equine vector-borne diseases in the UK
  9. Development and optimisation of Influenza C and Influenza D pseudotyped viruses
  10. Understanding the Molecular Interactions Between Influenza A Virus and Streptococcus Proteins in Co-Infection: A Scoping Review
  11. Should the equine community be concerned about the emergence of the H5N1 subtype of highly pathogenic avian influenza in US cattle?
  12. The Value of a Comparative Approach with Equine Vaccine Development for the Development of Human Influenza DNA Vaccines
  13. Role of pseudotyped viruses in understanding epidemiology, pathogenesis and immunity of viral diseases affecting both horses and humans
  14. Modelling the Influence of Climate and Vector Control Interventions on Arbovirus Transmission
  15. A systematic review quantifying host feeding patterns ofCulicoidesspecies responsible for pathogen transmission
  16. The Potential of Plant-Produced Virus-like Particle Vaccines for African Horse Sickness and Other Equine Orbiviruses
  17. Knowns and unknowns of TiLV-associated neuronal disease
  18. Development of Virus-like Particle Plant-Based Vaccines against Avian H5 and H9 Influenza A Viruses
  19. Systematic Review of Equine Influenza A Virus Vaccine Studies and Meta-Analysis of Vaccine Efficacy
  20. Advances in the understanding, detection and management of equine strangles
  21. Tilapia Lake Virus Vaccine Development: A Review on the Recent Advances
  22. Therapeutic Phage Display-Derived Single-Domain Antibodies for Pandemic Preparedness
  23. The persistence of equine strangles
  24. Seroprevalence of Equine Influenza and Its Associated Risk Factors in Northwest Nigeria
  25. An Equine Model for Vaccination against a Hepacivirus: Insights into Host Responses to E2 Recombinant Protein Vaccination and Subsequent Equine Hepacivirus Inoculation
  26. Inference for a spatio-temporal model with partial spatial data: African horse sickness virus in Morocco
  27. Gene Expression Profile Induced by Two Different Variants of Street Rabies Virus in Mice
  28. Development of Plant-Based Vaccines for Prevention of Avian Influenza and Newcastle Disease in Poultry
  29. Re‐parameterization of a mathematical model of African horse sickness virus using data from a systematic literature search
  30. Serological Cross-Reactions between Expressed VP2 Proteins from Different Bluetongue Virus Serotypes
  31. A Scoping Review of West Nile Virus Seroprevalence Studies among African Equids
  32. Perceptions and Experiences of the University of Nottingham Pilot SARS-CoV-2 Asymptomatic Testing Service: A Mixed-Methods Study
  33. Retrospective serological survey for influenza in horses from Brazil
  34. Systematic review and meta‐analysis of seroprevalence studies of West Nile virus in equids in Europe between 2001 and 2018
  35. Systematic review and meta-analysis of the seroprevalence of West Nile virus in equids in Europe between 2001 and 2018
  36. Evaluation of a Pseudotyped Virus Neutralisation Test for the Measurement of Equine Influenza Virus-Neutralising Antibody Responses Induced by Vaccination and Infection
  37. Serosurvey of pandemic H1N1 influenza A virus in dogs in Andalusia (southern Spain)
  38. Equine viral encephalitis: prevalence, impact, and management strategies
  39. Bluetongue virus outer-capsid protein VP2 expressed in Nicotiana benthamiana raises neutralising antibodies and a protective immune response in IFNAR −/− mice
  40. The challenges posed by equine arboviruses
  41. Strategic implementation of vaccines for control of equine influenza
  42. The Optimisation of Pseudotyped Viruses for the Characterisation of Immune Responses to Equine Influenza Virus
  43. The Influenza NS1 Protein: What Do We Know in Equine Influenza Virus Pathogenesis?
  44. Canine parvovirus study
  45. Making sense of altmetrics
  46. Controlling equine influenza: Traditional to next generation serological assays
  47. Small animal disease surveillance: respiratory disease
  48. Modulation of Potassium Channels Inhibits Bunyavirus Infection
  49. Technical considerations for the generation of novel pseudotyped viruses
  50. Diversity of group A rotavirus on a UK pig farm
  51. Seroprevalence of Schmallenberg virus in the United Kingdom and the Republic of Ireland: 2011–2013
  52. In memoriam – Richard M. Elliott (1954–2015)
  53. Comparison of Schmallenberg virus antibody levels detected in milk and serum from individual cows
  54. Identification of morphological differences between avian influenza A viruses grown in chicken and duck cells
  55. High Basal Expression of Interferon-Stimulated Genes in Human Bronchial Epithelial (BEAS-2B) Cells Contributes to Influenza A Virus Resistance
  56. Development of a surveillance scheme for equine influenza in the UK and characterisation of viruses isolated in Europe, Dubai and the USA from 2010–2012
  57. Pseudotypes: your flexible friends
  58. Potential of a sequence-based antigenic distance measure to indicate equine influenza vaccine strain efficacy
  59. The genetics of virus particle shape in equine influenza A virus
  60. Wildlife Vectors of Schmallenberg?
  61. What can mathematical models bring to the control of equine influenza?
  62. Current progress with serological assays for exotic emerging/re-emerging viruses
  63. SBV transmission
  64. Evolution of Equine Influenza Virus in Vaccinated Horses
  65. Testing for Schmallenberg Virus
  66. Schmallenberg virus
  67. Neuraminidase inhibitors for treatment of equine influenza – when all else fails?
  68. Recombination and positive selection identified in complete genome sequences of Japanese encephalitis virus
  69. herpesviruses in Egyptian rodents
  70. Antigenic and Genetic Evolution of Equine Influenza A (H3N8) Virus from 1968 to 2007
  71. Equine influenza: A review of an unpredictable virus
  72. Evaluation of two commercially available ELISAs for the diagnosis of Japanese encephalitis applied to field samples
  73. Intra- and Interhost Evolutionary Dynamics of Equine Influenza Virus
  74. Dynamics of Influenza Virus Infection and Pathology
  75. Quantifying the Impact of Immune Escape on Transmission Dynamics of Influenza
  76. Antigenic and genetic variations in European and North American equine influenza virus strains (H3N8) isolated from 2006 to 2007
  77. Control of equine influenza: scenario testing using a realistic metapopulation model of spread
  78. Vaccine failure caused an outbreak of equine influenza in Croatia
  79. Transmission of Equine Influenza Virus to English Foxhounds
  80. Protection, systemic IFNγ, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host
  81. Risk factors for influenza infection in vaccinated racehorses: Lessons from an outbreak in Newmarket, UK in 2003
  82. New assays to measure equine influenza virus-specific Type 1 immunity in horses
  83. Equine influenza vaccine containing older H3N8 strains offers protection against A/eq/South Africa/4/03 (H3N8) strain in a short‐term vaccine efficacy study
  84. Frequency and phenotype of EHV-1 specific, IFN-γ synthesising lymphocytes in ponies: The effects of age, pregnancy and infection
  85. Antibody and IFN-γ responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus
  86. Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro
  87. Vaccination against equine influenza: Quid novi?
  88. Characterisation of CTL and IFN-γ synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection
  89. Investigation of Equine Influenza Cases Exhibiting Neurological Disease: Coincidence or Association?
  90. Evaluation of the Binax NOW Flu A test kit for the rapid detection of equine influenza virus
  91. Description of the outbreak of equine influenza (H3N8) in the United Kingdom in 2003, during which recently vaccinated horses in Newmarket developed respiratory disease
  92. Equine influenza in dogs: Too late to bolt the stable door?
  93. The use of a systemic prime/mucosal boost strategy with an equine influenza ISCOM vaccine to induce protective immunity in horses
  94. Inhaled Zanamivir Versus Rimantadine for the Control of Influenza in a Highly Vaccinated Long-term Care Population
  95. Equine interferon gamma synthesis in lymphocytes after in vivo infection and in vitro stimulation with EHV-1
  96. Characterisation of three equine influenza A H3N8 viruses from Germany (2000 and 2002): Evidence for frozen evolution
  97. Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an ‘American lineage’ H3N8 virus
  98. Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines
  99. The effects of strain heterology on the epidemiology of equine influenza in a vaccinated population
  100. Current perspectives on control of equine influenza
  101. Unifying the Epidemiological and Evolutionary Dynamics of Pathogens
  102. Comparison of hamster and pony challenge models for evaluation of effect of antigenic drift on cross protection afforded by equine influenza vaccines
  103. Optimising vaccination strategies in equine influenza
  104. Diagnostic methods applied to analysis of an outbreak of equine influenza in a riding school in which vaccine failure occurred
  105. Influenza HA DNA induces Th1 cells and protection despite limited antibody responses
  106. Methods for determining resistance to neuraminidase inhibitors
  107. Viral Infections of the Equine Respiratory Tract
  108. Correspondence
  109. Antigenic and genetic evolution of equine H3N8 influenza A viruses
  110. Genetic and Antigenic Analysis of the Influenza Virus Responsible for the 1992 Hong Kong Equine Influenza Epizootic
  111. Genetic and antigenic analysis of an equine influenza H 3 isolate from the 1989 epidemic